Mercer Global Advisors
SER icon

Mercer Global Advisors’s Serina Therapeutics SER Stock Holding History

Mercer Global Advisors’s Portfolio SER Stock Details SER Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10 Buy
+5
New +$9 ﹤0.01% 6061

Other funds holding SER

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AWE
Avidian Wealth Enterprises Houston, Texas $3.62B AUM 24.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CIAM
Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PSB
Piscataqua Savings Bank Portsmouth, New Hampshire $148M AUM 32.61% 1-Year Est. Return
AFG
Albion Financial Group Salt Lake City, Utah $1.73B AUM 20.99% 1-Year Est. Return
PP
Pacifica Partners Surrey, Canada $332M AUM 59.28% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Mercer Global Advisors's SER Position: Q2 2026 in Review

Mercer Global Advisors opened a new position in Serina Therapeutics (SER) in Q2 2026: 5 shares worth $10. The stake represents ﹤0.01% of the portfolio and ranks #6061 among its holdings.

13 funds tracked by Wall St. Rank hold SER as of Q2 2026.

  • Mercer Global Advisors held 5 shares of Serina Therapeutics worth $10 as of Q2 2026.
  • Serina Therapeutics was a new Mercer Global Advisors position in Q2 2026.
  • Serina Therapeutics made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #6061 holding.
  • 13 funds tracked by Wall St. Rank held Serina Therapeutics as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.